Skip to main content
Premium Trial:

Request an Annual Quote

Making iPS Cells: A Common Lab Technique?

A group of scientists have created induced pluripotent stem cells from skin cells of patients with eight different diseases, reports the BBC. The stem cells, says the article, were created by taking biopsies from patients with diseases such as Huntington's and muscular dystrophy. "Ethical, flexible and not rejected by the patient because it comes from the patient themselves," said the UK National Stem Cell Network's Chris Mason. Two key challenges, however, remain: getting them safely into patients and avoiding side effects.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.